ClinicalTrials.govpublic full text
Natalizumab Treatment of Progressive Multiple Sclerosis
primary progressive multiple sclerosis, secondary progressive multiple sclerosis, natalizumab, treatment, safety, efficacy, cerebrospinal fluid, osteopontin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 843810
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.